Global In Vivo Toxicology Market Growth (Status and Outlook) 2024-2030

February 2024 | 111 pages | ID: GF6660506C9CEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global In Vivo Toxicology market size was valued at US$ 4103.1 million in 2023. With growing demand in downstream market, the In Vivo Toxicology is forecast to a readjusted size of US$ 6087.7 million by 2030 with a CAGR of 5.8% during review period.

The research report highlights the growth potential of the global In Vivo Toxicology market. In Vivo Toxicology are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of In Vivo Toxicology. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the In Vivo Toxicology market.

In vivo toxicology is usually carried out in animals as a whole, so that experimental animals in a certain period of time, according to the actual contact mode of human exposure to a certain amount of foreign compounds, and then observe the animal may appear in the form or function changes. Mammals are commonly used in experiments, such as rats, mice, guinea pigs, rabbits, hamsters, dogs and monkeys. The general toxicity of foreign compounds, such as acute toxicity test, subchronic toxicity test and chronic toxicity test, is usually detected.

Key Features:

The report on In Vivo Toxicology market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the In Vivo Toxicology market. It may include historical data, market segmentation by Type (e.g., Chronic Toxicity Testing, Sub-Chronic Toxicity Testing), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the In Vivo Toxicology market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the In Vivo Toxicology market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the In Vivo Toxicology industry. This include advancements in In Vivo Toxicology technology, In Vivo Toxicology new entrants, In Vivo Toxicology new investment, and other innovations that are shaping the future of In Vivo Toxicology.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the In Vivo Toxicology market. It includes factors influencing customer ' purchasing decisions, preferences for In Vivo Toxicology product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the In Vivo Toxicology market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting In Vivo Toxicology market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the In Vivo Toxicology market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the In Vivo Toxicology industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the In Vivo Toxicology market.

Market Segmentation:

In Vivo Toxicology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
  • Chronic Toxicity Testing
  • Sub-Chronic Toxicity Testing
  • Sub-Acute Toxicity Testing
  • Acute Toxicity Testing
Segmentation by application
  • Immunotoxicity
  • Systemic Toxicity
  • Carcinogenicity
  • Genotoxicity
  • Developmental and Reproductive Toxicity(DART)
  • Other Toxicity Endpoints
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Thermo Fisher Scientific
  • Danaher
  • Charles River Laboratories
  • Labcorp
  • The Jackson Laboratory
  • Data Sciences International
  • Envigo
  • Eurofins Scientific
  • Perkinelmer
  • SRI International
  • Taconic Biosciences
  • Wuxi Apptec
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global In Vivo Toxicology Market Size 2019-2030
  2.1.2 In Vivo Toxicology Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 In Vivo Toxicology Segment by Type
  2.2.1 Chronic Toxicity Testing
  2.2.2 Sub-Chronic Toxicity Testing
  2.2.3 Sub-Acute Toxicity Testing
  2.2.4 Acute Toxicity Testing
2.3 In Vivo Toxicology Market Size by Type
  2.3.1 In Vivo Toxicology Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global In Vivo Toxicology Market Size Market Share by Type (2019-2024)
2.4 In Vivo Toxicology Segment by Application
  2.4.1 Immunotoxicity
  2.4.2 Systemic Toxicity
  2.4.3 Carcinogenicity
  2.4.4 Genotoxicity
  2.4.5 Developmental and Reproductive Toxicity(DART)
  2.4.6 Other Toxicity Endpoints
2.5 In Vivo Toxicology Market Size by Application
  2.5.1 In Vivo Toxicology Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global In Vivo Toxicology Market Size Market Share by Application (2019-2024)

3 IN VIVO TOXICOLOGY MARKET SIZE BY PLAYER

3.1 In Vivo Toxicology Market Size Market Share by Players
  3.1.1 Global In Vivo Toxicology Revenue by Players (2019-2024)
  3.1.2 Global In Vivo Toxicology Revenue Market Share by Players (2019-2024)
3.2 Global In Vivo Toxicology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 IN VIVO TOXICOLOGY BY REGIONS

4.1 In Vivo Toxicology Market Size by Regions (2019-2024)
4.2 Americas In Vivo Toxicology Market Size Growth (2019-2024)
4.3 APAC In Vivo Toxicology Market Size Growth (2019-2024)
4.4 Europe In Vivo Toxicology Market Size Growth (2019-2024)
4.5 Middle East & Africa In Vivo Toxicology Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas In Vivo Toxicology Market Size by Country (2019-2024)
5.2 Americas In Vivo Toxicology Market Size by Type (2019-2024)
5.3 Americas In Vivo Toxicology Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC In Vivo Toxicology Market Size by Region (2019-2024)
6.2 APAC In Vivo Toxicology Market Size by Type (2019-2024)
6.3 APAC In Vivo Toxicology Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe In Vivo Toxicology by Country (2019-2024)
7.2 Europe In Vivo Toxicology Market Size by Type (2019-2024)
7.3 Europe In Vivo Toxicology Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa In Vivo Toxicology by Region (2019-2024)
8.2 Middle East & Africa In Vivo Toxicology Market Size by Type (2019-2024)
8.3 Middle East & Africa In Vivo Toxicology Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL IN VIVO TOXICOLOGY MARKET FORECAST

10.1 Global In Vivo Toxicology Forecast by Regions (2025-2030)
  10.1.1 Global In Vivo Toxicology Forecast by Regions (2025-2030)
  10.1.2 Americas In Vivo Toxicology Forecast
  10.1.3 APAC In Vivo Toxicology Forecast
  10.1.4 Europe In Vivo Toxicology Forecast
  10.1.5 Middle East & Africa In Vivo Toxicology Forecast
10.2 Americas In Vivo Toxicology Forecast by Country (2025-2030)
  10.2.1 United States In Vivo Toxicology Market Forecast
  10.2.2 Canada In Vivo Toxicology Market Forecast
  10.2.3 Mexico In Vivo Toxicology Market Forecast
  10.2.4 Brazil In Vivo Toxicology Market Forecast
10.3 APAC In Vivo Toxicology Forecast by Region (2025-2030)
  10.3.1 China In Vivo Toxicology Market Forecast
  10.3.2 Japan In Vivo Toxicology Market Forecast
  10.3.3 Korea In Vivo Toxicology Market Forecast
  10.3.4 Southeast Asia In Vivo Toxicology Market Forecast
  10.3.5 India In Vivo Toxicology Market Forecast
  10.3.6 Australia In Vivo Toxicology Market Forecast
10.4 Europe In Vivo Toxicology Forecast by Country (2025-2030)
  10.4.1 Germany In Vivo Toxicology Market Forecast
  10.4.2 France In Vivo Toxicology Market Forecast
  10.4.3 UK In Vivo Toxicology Market Forecast
  10.4.4 Italy In Vivo Toxicology Market Forecast
  10.4.5 Russia In Vivo Toxicology Market Forecast
10.5 Middle East & Africa In Vivo Toxicology Forecast by Region (2025-2030)
  10.5.1 Egypt In Vivo Toxicology Market Forecast
  10.5.2 South Africa In Vivo Toxicology Market Forecast
  10.5.3 Israel In Vivo Toxicology Market Forecast
  10.5.4 Turkey In Vivo Toxicology Market Forecast
  10.5.5 GCC Countries In Vivo Toxicology Market Forecast
10.6 Global In Vivo Toxicology Forecast by Type (2025-2030)
10.7 Global In Vivo Toxicology Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Thermo Fisher Scientific
  11.1.1 Thermo Fisher Scientific Company Information
  11.1.2 Thermo Fisher Scientific In Vivo Toxicology Product Offered
  11.1.3 Thermo Fisher Scientific In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Thermo Fisher Scientific Main Business Overview
  11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Danaher
  11.2.1 Danaher Company Information
  11.2.2 Danaher In Vivo Toxicology Product Offered
  11.2.3 Danaher In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Danaher Main Business Overview
  11.2.5 Danaher Latest Developments
11.3 Charles River Laboratories
  11.3.1 Charles River Laboratories Company Information
  11.3.2 Charles River Laboratories In Vivo Toxicology Product Offered
  11.3.3 Charles River Laboratories In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Charles River Laboratories Main Business Overview
  11.3.5 Charles River Laboratories Latest Developments
11.4 Labcorp
  11.4.1 Labcorp Company Information
  11.4.2 Labcorp In Vivo Toxicology Product Offered
  11.4.3 Labcorp In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Labcorp Main Business Overview
  11.4.5 Labcorp Latest Developments
11.5 The Jackson Laboratory
  11.5.1 The Jackson Laboratory Company Information
  11.5.2 The Jackson Laboratory In Vivo Toxicology Product Offered
  11.5.3 The Jackson Laboratory In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 The Jackson Laboratory Main Business Overview
  11.5.5 The Jackson Laboratory Latest Developments
11.6 Data Sciences International
  11.6.1 Data Sciences International Company Information
  11.6.2 Data Sciences International In Vivo Toxicology Product Offered
  11.6.3 Data Sciences International In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Data Sciences International Main Business Overview
  11.6.5 Data Sciences International Latest Developments
11.7 Envigo
  11.7.1 Envigo Company Information
  11.7.2 Envigo In Vivo Toxicology Product Offered
  11.7.3 Envigo In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Envigo Main Business Overview
  11.7.5 Envigo Latest Developments
11.8 Eurofins Scientific
  11.8.1 Eurofins Scientific Company Information
  11.8.2 Eurofins Scientific In Vivo Toxicology Product Offered
  11.8.3 Eurofins Scientific In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Eurofins Scientific Main Business Overview
  11.8.5 Eurofins Scientific Latest Developments
11.9 Perkinelmer
  11.9.1 Perkinelmer Company Information
  11.9.2 Perkinelmer In Vivo Toxicology Product Offered
  11.9.3 Perkinelmer In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Perkinelmer Main Business Overview
  11.9.5 Perkinelmer Latest Developments
11.10 SRI International
  11.10.1 SRI International Company Information
  11.10.2 SRI International In Vivo Toxicology Product Offered
  11.10.3 SRI International In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 SRI International Main Business Overview
  11.10.5 SRI International Latest Developments
11.11 Taconic Biosciences
  11.11.1 Taconic Biosciences Company Information
  11.11.2 Taconic Biosciences In Vivo Toxicology Product Offered
  11.11.3 Taconic Biosciences In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Taconic Biosciences Main Business Overview
  11.11.5 Taconic Biosciences Latest Developments
11.12 Wuxi Apptec
  11.12.1 Wuxi Apptec Company Information
  11.12.2 Wuxi Apptec In Vivo Toxicology Product Offered
  11.12.3 Wuxi Apptec In Vivo Toxicology Revenue, Gross Margin and Market Share (2019-2024)
  11.12.4 Wuxi Apptec Main Business Overview
  11.12.5 Wuxi Apptec Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. In Vivo Toxicology Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Chronic Toxicity Testing
Table 3. Major Players of Sub-Chronic Toxicity Testing
Table 4. Major Players of Sub-Acute Toxicity Testing
Table 5. Major Players of Acute Toxicity Testing
Table 6. In Vivo Toxicology Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global In Vivo Toxicology Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global In Vivo Toxicology Market Size Market Share by Type (2019-2024)
Table 9. In Vivo Toxicology Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global In Vivo Toxicology Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global In Vivo Toxicology Market Size Market Share by Application (2019-2024)
Table 12. Global In Vivo Toxicology Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global In Vivo Toxicology Revenue Market Share by Player (2019-2024)
Table 14. In Vivo Toxicology Key Players Head office and Products Offered
Table 15. In Vivo Toxicology Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global In Vivo Toxicology Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global In Vivo Toxicology Market Size Market Share by Regions (2019-2024)
Table 20. Global In Vivo Toxicology Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global In Vivo Toxicology Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas In Vivo Toxicology Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas In Vivo Toxicology Market Size Market Share by Country (2019-2024)
Table 24. Americas In Vivo Toxicology Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas In Vivo Toxicology Market Size Market Share by Type (2019-2024)
Table 26. Americas In Vivo Toxicology Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas In Vivo Toxicology Market Size Market Share by Application (2019-2024)
Table 28. APAC In Vivo Toxicology Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC In Vivo Toxicology Market Size Market Share by Region (2019-2024)
Table 30. APAC In Vivo Toxicology Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC In Vivo Toxicology Market Size Market Share by Type (2019-2024)
Table 32. APAC In Vivo Toxicology Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC In Vivo Toxicology Market Size Market Share by Application (2019-2024)
Table 34. Europe In Vivo Toxicology Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe In Vivo Toxicology Market Size Market Share by Country (2019-2024)
Table 36. Europe In Vivo Toxicology Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe In Vivo Toxicology Market Size Market Share by Type (2019-2024)
Table 38. Europe In Vivo Toxicology Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe In Vivo Toxicology Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa In Vivo Toxicology Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa In Vivo Toxicology Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa In Vivo Toxicology Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa In Vivo Toxicology Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa In Vivo Toxicology Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa In Vivo Toxicology Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of In Vivo Toxicology
Table 47. Key Market Challenges & Risks of In Vivo Toxicology
Table 48. Key Industry Trends of In Vivo Toxicology
Table 49. Global In Vivo Toxicology Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global In Vivo Toxicology Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global In Vivo Toxicology Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global In Vivo Toxicology Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Thermo Fisher Scientific Details, Company Type, In Vivo Toxicology Area Served and Its Competitors
Table 54. Thermo Fisher Scientific In Vivo Toxicology Product Offered
Table 55. Thermo Fisher Scientific In Vivo Toxicology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Thermo Fisher Scientific Main Business
Table 57. Thermo Fisher Scientific Latest Developments
Table 58. Danaher Details, Company Type, In Vivo Toxicology Area Served and Its Competitors
Table 59. Danaher In Vivo Toxicology Product Offered
Table 60. Danaher Main Business
Table 61. Danaher In Vivo Toxicology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Danaher Latest Developments
Table 63. Charles River Laboratories Details, Company Type, In Vivo Toxicology Area Served and Its Competitors
Table 64. Charles River Laboratories In Vivo Toxicology Product Offered
Table 65. Charles River Laboratories Main Business
Table 66. Charles River Laboratories In Vivo Toxicology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Charles River Laboratories Latest Developments
Table 68. Labcorp Details, Company Type, In Vivo Toxicology Area Served and Its Competitors
Table 69. Labcorp In Vivo Toxicology Product Offered
Table 70. Labcorp Main Business
Table 71. Labcorp In Vivo Toxicology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Labcorp Latest Developments
Table 73. The Jackson Laboratory Details, Company Type, In Vivo Toxicology Area Served and Its Competitors
Table 74. The Jackson Laboratory In Vivo Toxicology Product Offered
Table 75. The Jackson Laboratory Main Business
Table 76. The Jackson Laboratory In Vivo Toxicology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. The Jackson Laboratory Latest Developments
Table 78. Data Sciences International Details, Company Type, In Vivo Toxicology Area Served and Its Competitors
Table 79. Data Sciences International In Vivo Toxicology Product Offered
Table 80. Data Sciences International Main Business
Table 81. Data Sciences International In Vivo Toxicology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Data Sciences International Latest Developments
Table 83. Envigo Details, Company Type, In Vivo Toxicology Area Served and Its Competitors
Table 84. Envigo In Vivo Toxicology Product Offered
Table 85. Envigo Main Business
Table 86. Envigo In Vivo Toxicology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Envigo Latest Developments
Table 88. Eurofins Scientific Details, Company Type, In Vivo Toxicology Area Served and Its Competitors
Table 89. Eurofins Scientific In Vivo Toxicology Product Offered
Table 90. Eurofins Scientific Main Business
Table 91. Eurofins Scientific In Vivo Toxicology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Eurofins Scientific Latest Developments
Table 93. Perkinelmer Details, Company Type, In Vivo Toxicology Area Served and Its Competitors
Table 94. Perkinelmer In Vivo Toxicology Product Offered
Table 95. Perkinelmer Main Business
Table 96. Perkinelmer In Vivo Toxicology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Perkinelmer Latest Developments
Table 98. SRI International Details, Company Type, In Vivo Toxicology Area Served and Its Competitors
Table 99. SRI International In Vivo Toxicology Product Offered
Table 100. SRI International Main Business
Table 101. SRI International In Vivo Toxicology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. SRI International Latest Developments
Table 103. Taconic Biosciences Details, Company Type, In Vivo Toxicology Area Served and Its Competitors
Table 104. Taconic Biosciences In Vivo Toxicology Product Offered
Table 105. Taconic Biosciences In Vivo Toxicology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Taconic Biosciences Main Business
Table 107. Taconic Biosciences Latest Developments
Table 108. Wuxi Apptec Details, Company Type, In Vivo Toxicology Area Served and Its Competitors
Table 109. Wuxi Apptec In Vivo Toxicology Product Offered
Table 110. Wuxi Apptec Main Business
Table 111. Wuxi Apptec In Vivo Toxicology Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Wuxi Apptec Latest Developments

LIST OF FIGURES

Figure 1. In Vivo Toxicology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global In Vivo Toxicology Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. In Vivo Toxicology Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. In Vivo Toxicology Sales Market Share by Country/Region (2023)
Figure 8. In Vivo Toxicology Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global In Vivo Toxicology Market Size Market Share by Type in 2023
Figure 10. In Vivo Toxicology in Immunotoxicity
Figure 11. Global In Vivo Toxicology Market: Immunotoxicity (2019-2024) & ($ Millions)
Figure 12. In Vivo Toxicology in Systemic Toxicity
Figure 13. Global In Vivo Toxicology Market: Systemic Toxicity (2019-2024) & ($ Millions)
Figure 14. In Vivo Toxicology in Carcinogenicity
Figure 15. Global In Vivo Toxicology Market: Carcinogenicity (2019-2024) & ($ Millions)
Figure 16. In Vivo Toxicology in Genotoxicity
Figure 17. Global In Vivo Toxicology Market: Genotoxicity (2019-2024) & ($ Millions)
Figure 18. In Vivo Toxicology in Developmental and Reproductive Toxicity(DART)
Figure 19. Global In Vivo Toxicology Market: Developmental and Reproductive Toxicity(DART) (2019-2024) & ($ Millions)
Figure 20. In Vivo Toxicology in Other Toxicity Endpoints
Figure 21. Global In Vivo Toxicology Market: Other Toxicity Endpoints (2019-2024) & ($ Millions)
Figure 22. Global In Vivo Toxicology Market Size Market Share by Application in 2023
Figure 23. Global In Vivo Toxicology Revenue Market Share by Player in 2023
Figure 24. Global In Vivo Toxicology Market Size Market Share by Regions (2019-2024)
Figure 25. Americas In Vivo Toxicology Market Size 2019-2024 ($ Millions)
Figure 26. APAC In Vivo Toxicology Market Size 2019-2024 ($ Millions)
Figure 27. Europe In Vivo Toxicology Market Size 2019-2024 ($ Millions)
Figure 28. Middle East & Africa In Vivo Toxicology Market Size 2019-2024 ($ Millions)
Figure 29. Americas In Vivo Toxicology Value Market Share by Country in 2023
Figure 30. United States In Vivo Toxicology Market Size Growth 2019-2024 ($ Millions)
Figure 31. Canada In Vivo Toxicology Market Size Growth 2019-2024 ($ Millions)
Figure 32. Mexico In Vivo Toxicology Market Size Growth 2019-2024 ($ Millions)
Figure 33. Brazil In Vivo Toxicology Market Size Growth 2019-2024 ($ Millions)
Figure 34. APAC In Vivo Toxicology Market Size Market Share by Region in 2023
Figure 35. APAC In Vivo Toxicology Market Size Market Share by Type in 2023
Figure 36. APAC In Vivo Toxicology Market Size Market Share by Application in 2023
Figure 37. China In Vivo Toxicology Market Size Growth 2019-2024 ($ Millions)
Figure 38. Japan In Vivo Toxicology Market Size Growth 2019-2024 ($ Millions)
Figure 39. Korea In Vivo Toxicology Market Size Growth 2019-2024 ($ Millions)
Figure 40. Southeast Asia In Vivo Toxicology Market Size Growth 2019-2024 ($ Millions)
Figure 41. India In Vivo Toxicology Market Size Growth 2019-2024 ($ Millions)
Figure 42. Australia In Vivo Toxicology Market Size Growth 2019-2024 ($ Millions)
Figure 43. Europe In Vivo Toxicology Market Size Market Share by Country in 2023
Figure 44. Europe In Vivo Toxicology Market Size Market Share by Type (2019-2024)
Figure 45. Europe In Vivo Toxicology Market Size Market Share by Application (2019-2024)
Figure 46. Germany In Vivo Toxicology Market Size Growth 2019-2024 ($ Millions)
Figure 47. France In Vivo Toxicology Market Size Growth 2019-2024 ($ Millions)
Figure 48. UK In Vivo Toxicology Market Size Growth 2019-2024 ($ Millions)
Figure 49. Italy In Vivo Toxicology Market Size Growth 2019-2024 ($ Millions)
Figure 50. Russia In Vivo Toxicology Market Size Growth 2019-2024 ($ Millions)
Figure 51. Middle East & Africa In Vivo Toxicology Market Size Market Share by Region (2019-2024)
Figure 52. Middle East & Africa In Vivo Toxicology Market Size Market Share by Type (2019-2024)
Figure 53. Middle East & Africa In Vivo Toxicology Market Size Market Share by Application (2019-2024)
Figure 54. Egypt In Vivo Toxicology Market Size Growth 2019-2024 ($ Millions)
Figure 55. South Africa In Vivo Toxicology Market Size Growth 2019-2024 ($ Millions)
Figure 56. Israel In Vivo Toxicology Market Size Growth 2019-2024 ($ Millions)
Figure 57. Turkey In Vivo Toxicology Market Size Growth 2019-2024 ($ Millions)
Figure 58. GCC Country In Vivo Toxicology Market Size Growth 2019-2024 ($ Millions)
Figure 59. Americas In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 60. APAC In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 61. Europe In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 62. Middle East & Africa In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 63. United States In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 64. Canada In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 65. Mexico In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 66. Brazil In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 67. China In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 68. Japan In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 69. Korea In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 70. Southeast Asia In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 71. India In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 72. Australia In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 73. Germany In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 74. France In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 75. UK In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 76. Italy In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 77. Russia In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 78. Spain In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 79. Egypt In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 80. South Africa In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 81. Israel In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 82. Turkey In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 83. GCC Countries In Vivo Toxicology Market Size 2025-2030 ($ Millions)
Figure 84. Global In Vivo Toxicology Market Size Market Share Forecast by Type (2025-2030)
Figure 85. Global In Vivo Toxicology Market Size Market Share Forecast by Application (2025-2030)


More Publications